The Treatment Outcomes of Cesarean Scar Pregnancy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorWomen's Hospital School Of Medicine Zhejiang University

About this trial

A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women over 18 years old with a history of cesarean section

Ultrasound diagnosis of cesarean scar pregnancy

No severe internal or external diseases, such as liver disease, kidney disease, cardiovascular disease, cerebrovascular disease, etc., and able to tolerate surgery

Disqualifiers

Women under the age of 18

CSP patients who have received treatment in other hospitals

Trial population

A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes. The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach. Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • different surgical treatment

    Other intervention

    The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach. Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.

Treatment groups

82 Participants
are divided into 2 treatment groups
Group A: excisional surgery group1 intervention
Group B: conservative surgery group1 intervention

Trial outcomes

Primary outcomes

1

successful surgical treatment

successful treatment rate after surgery

Time frame
One day after surgery

Secondary outcomes

1

complication

severe complication rate after surgery

Time frame
One day after surgery

Other outcomes

1

subsequent pregnancy rate

subsequent pregnancy rate after surgery

Time frame
Up to 24 months after surgery without contraception and the time since the last menstrual period is 4 weeks or more.
2

CSP recurrence rate

CSP recurrence rate after surgery

Time frame
Up to 24 months after surgery without contraception
3

pregnancy interval

pregnancy interval after surgery

Time frame
Up to 24 months (the time interval between the cessation of contraception after surgery and the time of last menstrual period of the subsequent pregnancy)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.